Leases - Additional Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Lessee, Lease, Description [Line Items] | |||
| Lease not yet commenced | As of June 30, 2026, the Company has one lease which has not yet commenced or been recognized, since the facility is not yet available for the Company’s use. | ||
| Fixed lease payments | $ 1,300,000 | ||
| Operating lease right-of-use assets | 35,798,000 | $ 35,798,000 | $ 26,130,000 |
| Lease liability | $ 41,459,000 | $ 41,459,000 | |
| Initial term of the lease | 5 years | 5 years | |
| Future minimum lease payments | $ 79,909,000 | $ 79,909,000 | |
| Future minimum lease payments due in next 12 months | 5,929,000 | 5,929,000 | |
| Restricted Cash Held As Collateral | |||
| Lessee, Lease, Description [Line Items] | |||
| Restricted cash | 1,300,000 | $ 1,300,000 | |
| New Operating Lease Facility | |||
| Lessee, Lease, Description [Line Items] | |||
| Operating lease description | In November 2021, the Company entered into a noncancelable operating lease for its current headquarters. The lease, as amended, commenced in January 2022 and expires in January 2034. A portion of the facility was subleased to Attovia Therapeutics, Inc. (“Attovia”), a related party, through March 2025. | ||
| Lease for Manufacturing, Research and Office Space in Fremont, California | |||
| Lessee, Lease, Description [Line Items] | |||
| Operating lease right-of-use assets | 10,800,000 | $ 10,800,000 | |
| Lease liability | $ 10,700,000 | $ 10,700,000 | |
| Initial term of the lease | 158 months | 158 months | |
| Option to extend the lease, description | the Company has an option to extend the lease for one additional 5-year term. | ||
| Option to extend the lease | true | ||
| Extend term of the lease | 5 years | 5 years | |
| Maximum | Lease for Manufacturing, Research and Office Space in Fremont, California | |||
| Lessee, Lease, Description [Line Items] | |||
| Tenant improvement allowances receivable | $ 7,700,000 |